Guest Editor(s)

• Prof. Gunnar Kristensen

  Department for Gynecologic Oncology and Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.

  Website | E-mail

Special Issue Introduction

Cervical cancer is the leading cause of cancer deaths in some low income countries and number 4 worldwide. HPV vaccination will reduce the burden in the long run. Effective screening programs will help diagnosing new cases at a treatable stage of the disease. Treatment programs based on available resources and best knowledge are important. This special issue will focus on all aspects of treatment strategies and welcome all key findings that can help improve oncologic outcome and quality of life for the patients.

Aimed topics can be, but are not confined to:
Clinical diagnosis and assessment
Imaging
Strategies to select optimal treatment
Improvements in surgical technique
Improvements in radiation technique
Neoadjuvant treatment
Treatment of advanced disease.

Participants

1. Gabriele Siesto  Humanitas Research Hospital, Rozzano, Italy.
2. Antonio Casado Hospital Clínico San Carlos de Madrid, Madrid, Spain.
3. Paolo Zola Università degli Studi di Torino, Turin, Italy.
4. Kristina Hellman Karolinska University Hospital, Stockholm, Sweden.
5. Michael Höckel Universitätsklinikum Leipzig und Medizinische Fakultät, Leipzig, Germany.
The list is arranged in no particular order and being updated.

Submission Deadline

30 Mar 2022

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://jcmtjournal.com/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jcmt&SpecialIssueId=594
Submission Deadline: 30 Mar 2022
Contacts: Carl Zhou, Assistant Editor, Carl.Zhou@jcmtjournal.com